Solifenacina/Tansulosina Generis

Medicinal product

(Invented) name

Solifenacina/Tansulosina Generis

Active substance (s)

Solifenacino sukcinatas/Tamsulozino hidrochloridas

Strength

6 mg/0,4 mg

Pharmaceutical form

modifikuoto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04CA53, Tamsulosin and solifenacin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-07-17

Date of renewal

Documents

2707_Solifenacina_Tansulosina Generis 6mg-0,4mg_tab_PZ_2025-07-17.docx

2707_Solifenacina_Tansulosina Generis 6mg-0,4mg_tab_PL_2025-07-17.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Solifenacino sukcinatas	6 mg
Tamsulozino hidrochloridas	0,4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117963	104068	1104068	lizdinė plokštelė	N30		Receptinis	LT/L/25/2707/001	Tiekiama	2025-10-01	-	No	-	-	Download

Stadijos

Data	Stadija
2025-07-17	Registruotas